tolbutamide has been researched along with EHS Tumor in 2 studies
Tolbutamide: A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290)
tolbutamide : An N-sulfonylurea that consists of 1-butylurea having a tosyl group attached at the 3-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Singh, J | 1 |
| Grigor, MR | 1 |
| Thompson, MP | 1 |
| Blumberg, D | 1 |
| Burt, ME | 1 |
| Kher, U | 1 |
| Brennan, MF | 1 |
2 other studies available for tolbutamide and EHS Tumor
| Article | Year |
|---|---|
Glucose tolerance and hormonal changes in rats bearing a transplantable sarcoma.
Topics: Animals; Blood Glucose; Female; Glucagon; Glucose Tolerance Test; Insulin; Kinetics; Male; Neoplasm | 1981 |
Tolbutamide inhibits gluconeogenesis in the tumor-influenced hepatocyte.
Topics: Alanine; Animals; Gluconeogenesis; Lactates; Lactic Acid; Liver; Male; Methylcholanthrene; Neoplasm | 1993 |